M. Hardy

发表

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women

C. McBride, B. Peshkin, M. Schwartz, 2022, Journal of Community Genetics.

Patients' reactions and follow‐up testing decisions related to Tay‐Sachs (HEXA) variants of uncertain significance results

C. Bellcross, Reneé H Moore, Patricia Z. Page, 2019, Journal of genetic counseling.

Evaluating the experiences of individuals with personal health risks identified through expanded carrier screening

M. Hardy, K. Grinzaid, N. Ali, 2021, Journal of genetic counseling.

Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study

C. Stanislaw, E. Rose, M. Hardy, 2022, Public Health Genomics.

Telehealth for genetic counseling: A systematic evidence review

Kate P Shane-Carson, M. Hardy, Rachel Nusbaum, 2021, Journal of genetic counseling.

Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort

D. Muzzey, I. Haque, Patricia Z. Page, 2019, Molecular genetics & genomic medicine.

Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth

M. Hardy, K. Grinzaid, Hillary J Kener, 2018, Public Health Genomics.

Benefits and Challenges of Telemedicine: the JScreen Program Experience

Melanie Walker Hardy, Karen A. Grinzaid, M. Hardy, 2017, Current Genetic Medicine Reports.

Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort

D. Muzzey, I. Haque, Patricia Z. Page, 2019, Molecular genetics & genomic medicine.

Analysis of the reported use of practice‐based competencies by North American genetic counselors during the COVID‐19 pandemic

L. Ryan, N. Wagner, M. Hardy, 2021, Journal of genetic counseling.